CELLDEX
LIVE

Serial Number

86740171

Owner

Celldex Therapeutics, Inc.

Attorney

Matthew Hintz, Esq.

First Use Date

Apr 13, 2009

Filing Date

Aug 28, 2015

Add to watchlist:

No watchlists yet
View on USPTO

CELLDEX Trademark

Serial Number: 86740171 • Registration: 5076311

CELLDEX is a trademark filed by Celldex Therapeutics, Inc. on August 28, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Celldex Therapeutics, Inc. (36 trademarks)

519 Route 173 West
Bloomsbury, NJ 08804

Entity Type: 03

Trademark Details

Filing Date

August 28, 2015

Registration Date

November 8, 2016

First Use Anywhere

April 13, 2009

First Use in Commerce

April 13, 2009

Published for Opposition

August 23, 2016

Goods & Services

[ Vaccines; Therapeutic vaccines; ] Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for immunotherapy treatment; [ Antibody drug conjugates, namely, pharmaceutical preparations for the treatment of cancer, and for the treatment of diseases of the integumentary system and reproductive system; ] Pharmaceutical preparations derived from monoclonal antibodies for the treatment of cancer, [ and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; ] Therapeutic antibodies and immune system modulators, namely, pharmaceutical preparations for the treatment of cancer, [ and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; Pharmaceutical preparations and substances for use as vaccine adjuvants, growth factors, namely, ligands and proteins for stem cells in stem cell mobilization; ] pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, [ immune system stimulators and ] immune system modulators

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 8, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 3, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 3, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 3, 2023 APRE
TEAS SECTION 8 & 15 RECEIVED
May 8, 2023 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 8, 2021 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 8, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 23, 2016 NPUB
PUBLISHED FOR OPPOSITION
Aug 23, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 3, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2015 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2015 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2015 CNRT
ASSIGNED TO EXAMINER
Dec 11, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2015 NWOS
NEW APPLICATION ENTERED
Sep 1, 2015 NWAP